Gossamer Bio
GOSS
GOSS
96 hedge funds and large institutions have $410M invested in Gossamer Bio in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
35% less capital invested
Capital invested by funds: $632M → $410M (-$221M)
70% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $3.66M
Holders
96
Holding in Top 10
1
Calls
$1.09M
Puts
$3.66M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$3.7M | |
| 3 | +$2.77M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$2.03M |
| 5 |
Morgan Stanley
New York
|
+$1.08M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$4.06M | |
| 3 | -$3.29M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.29M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$1.17M |